Skip to main content

Table 1 Breakdown of different costs per diagnosed type 2 diabetes patient in the Singapore male working-age population by age group from 2010 to 2050 (in USD)

From: Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050

Year

Age group

Diabetes population

Indirect productivity loss

Total economic costa

Absenteeism

Presenteeism

Diabetes-related non-participation

Lost capacity from premature mortality

Total indirect cost

2010

20–29

2,396

150

1,614

-

-

1,764

3,260

30–39

8,205

260

2,795

-

1,874

4,929

6,425

40–49

19,334

229

2,464

-

3,428

6,121

7,617

50–59

27,760

144

1,555

1,270

4,109

7,078

8,574

60–69

21,114

67

722

240

2,340

3,369

4,865

2030

20–29

2,920

225

2,426

-

394

3,046

4,542

30–39

10,149

386

4,154

-

1,974

6,513

8,009

40–49

22,004

340

3,663

-

3,821

7,824

9,320

50–59

35,009

213

2,296

1,882

5,256

9,648

11,144

60–69

50,298

95

1,022

229

2,461

3,806

5,302

2050

20–29

3,238

340

3,657

-

-

3,996

5,492

30–39

12,013

573

6,172

-

2,520

9,265

10,761

40–49

25,323

505

5,442

-

4,512

10,459

11,955

50–59

42,216

318

3,422

2,748

5,186

11,674

13,170

60–69

58,576

142

1,534

394

2,326

4,397

5,893

  1. aTotal economic cost = Total indirect cost + Excess direct medical cost of US$1,496.03